June’s top stories: FDA cyber threat warning, MicroPort to buy OrthoRecon

ClearCell FX system allows doctors to quickly separate tumour cells circulating in a patient’s bloodstream, thereby paving the way for a personalised medicine. Photo courtesy of Cambridge Consultants.